FIXX insider trading
NYSE American HealthcareHomology Medicines, Inc.: insider trade history from SEC Form 4 filings.
About Homology Medicines, Inc.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Company website: www.homologymedicines.com
FIXX insider activity at a glance
FilingIQ tracks 179 insider transactions for FIXX in filings since Apr 4, 2018. The most recent transaction is dated Mar 25, 2024.
Across the full history, 6 open-market purchases
and 106 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest FIXX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for FIXX?
- FilingIQ tracks 179 Form 4 insider transactions for FIXX (Homology Medicines, Inc.), covering filings from Apr 4, 2018 onwards. 0 of those are dated within the last 90 days.
- Are FIXX insiders net buyers or net sellers?
- Across the full Form 4 history for FIXX, 6 transactions (3%) were open-market purchases and 106 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does FIXX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is FIXX in?
- Homology Medicines, Inc. (FIXX) is classified in the Healthcare sector, specifically Biotechnology.
Methodology & sources
Every FIXX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.